Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
GURNEE, Ill., Aug. 16, 2022 -- (Healthcare Sales & Marketing Network) -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic version of Cetrorelix Acetate for Injection, 0.25 mg (Cetroreli... Biopharmaceuticals, Generics, FDA Akorn, Cetrorelix, Cetrotide (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 16, 2022 Category: Pharmaceuticals Source Type: news

Alternative Pathway Blocker Anti-Bb Antibody (NM8074) Receives US FDA Clearance to Start Efficacy Trial in C3 Glomerulopathy (C3G) Patients
FDA Clears Initiation of Efficacy Trial for C3 Glomerulopathy (C3G) CLEVELAND, Aug. 15, 2022 -- (Healthcare Sales & Marketing Network) -- NovelMed Therapeutics is a clinical-stage biopharmaceutical company focused on the development of targeted therapi... Biopharmaceuticals, FDA NovelMed Therapeutics, Anti-Bb Antibody, Glomerulopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 15, 2022 Category: Pharmaceuticals Source Type: news

Boston Scientific Announces Acquisition of Obsidio, Inc.
Company to add novel technology cleared for use in peripheral vasculature to interventional oncology and embolization portfolio MARLBOROUGH, Mass., Aug. 15, 2022 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) tod... Devices, Interventional, Mergers & Acquisitions Boston Scientific, Obsidio, Gel Embolic Material, embolization (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 15, 2022 Category: Pharmaceuticals Source Type: news

Zeta Surgical Appoints Professor James Choi as Focused Ultrasound Lead in Push for Incision-less Brain Surgery
BOSTON, Aug. 12, 2022 -- (Healthcare Sales & Marketing Network) -- Zeta Surgical, a surgical robotics and mixed reality company, has appointed Dr. James Choi from Imperial College London as Focused Ultrasound Lead. Dr. Choi will head the development of a... Devices, Neurosurgery, Personnel Zeta Surgical, digital surgery, neurosurgical navigation, robotic surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 12, 2022 Category: Pharmaceuticals Source Type: news

Chemomab Adds Highly Experienced Executives Further Strengthening Its RandD and Clinical Capabilities
Appoints Ilan Vaknin, PhD, as Vice President of Research & Development and Christina Crater, MD, as Vice President of Clinical Development TEL AVIV, Israel, Aug. 12, 2022 -- (Healthcare Sales & Marketing Network) -- Chemomab Therapeutics, Ltd. (Nasdaq... Biopharmaceuticals, Personnel Chemomab Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 12, 2022 Category: Pharmaceuticals Source Type: news

Cardinal Health Announces Leadership Changes
Mike Kaufmann to Step Down as Chief Executive Officer and from Board of Directors Jason Hollar, Chief Financial Officer, Named Chief Executive Officer Patricia English to Serve as Interim Chief Financial Officer DUBLIN, Ohio, Aug. 11, 2022 -- (Hea... Devices, Biopharmaceuticals, Distribution, Personnel Cardinal Health (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 11, 2022 Category: Pharmaceuticals Source Type: news

New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models
Fluidx Medical's GPX Embolic Material Yields Promising Results for Oncology Uses SALT LAKE CITY, Aug. 10, 2022 -- (Healthcare Sales & Marketing Network) -- Fluidx Medical disclosed study results examining extent of vessel filling using the GPX Embolic ... Devices, Interventional Fluidx Medical Technology, GPX Embolic Device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 10, 2022 Category: Pharmaceuticals Source Type: news

GentiBio Announces Collaboration with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for Inflammatory Bowel Diseases
Collaboration combines GentiBio's best-in-class engineered regulatory T cell platform with Bristol Myers Squibb's leadership in cell therapy and immunology drug development GentiBio to receive upfront cash payment, up to $1.9 billion in potential future... Biopharmaceuticals, Gastroenterology GentiBio , Bristol Myers Squibb, engineered Treg, inflammatory bowel diseases (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 10, 2022 Category: Pharmaceuticals Source Type: news

CereVasc Announces FDA Approval of Second IDE Study of the eShunt(R) System
US Based Pilot Study to enroll patients who develop communicating hydrocephalus following subarachnoid hemorrhage BOSTON, Aug. 9, 2022 -- (Healthcare Sales & Marketing Network) -- CereVasc, Inc., a privately held, clinical-stage, medical device company... Devices, Neurosurgery, Interventional, FDA CereVasc , eShunt System, hydrocephalus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 9, 2022 Category: Pharmaceuticals Source Type: news

ImmPACT Bio Names Vikram Lamba as Chief Financial Officer and Head of Business Development
Senior healthcare executive with three decades' global experience across large pharma and diverse start-up organizations in finance and business development WEST HILLS, Calif., Aug. 9, 2022 -- (Healthcare Sales & Marketing Network) -- ImmPACT Bio USA, ... Biopharmaceuticals, Oncology, Personnel ImmPACT Bio, chimeric antigen receptor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 9, 2022 Category: Pharmaceuticals Source Type: news

MicroPort Navibot Receives 510(K) Clearance for its SkyWalker(TM) Robot-Assisted Platform for Orthopedic Applications
ARLINGTON, Tenn., Aug. 8, 2022 -- (Healthcare Sales & Marketing Network) -- MicroPort Navibot has received 510(K) clearance from the Food and Drug Administration (FDA) in the United States for the SkyWalker™ System, the company's first robot-assisted plat... Devices, Orthopaedic, FDA MicroPort Navibot, SkyWalker, robotic surgery, total knee (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 8, 2022 Category: Pharmaceuticals Source Type: news

Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion
Tarcocimab tedromer (KSI-301) dosed every two months met the primary endpoint of non-inferior visual acuity gains compared to aflibercept dosed every month First anti-VEGF therapy to achieve non-inferiority in visual acuity gains while doubling the trea... Biopharmaceuticals, Ophthalmology Kodiak Sciences, tarcocimab tedromer, retinal vein occlusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 8, 2022 Category: Pharmaceuticals Source Type: news

Vieworks Wins FDA Approval for its Newest VIVIX-S F Series
ANYANG, South Korea, Aug. 5, 2022 -- (Healthcare Sales & Marketing Network) -- Vieworks, a leading digital X-ray imaging solution provider based in South Korea, noted that its newest VIVIX-S F series has been authorized by the US Food and Drug Administrat... Devices, Radiology, FDA Vieworks, VIVIX-S F, X-ray DR, flat panel detector (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 5, 2022 Category: Pharmaceuticals Source Type: news

Amgen to Acquire Chemocentryx for $4 Billion in Cash
Acquisition Includes TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Serious Autoimmune Disease Tavneos Adds to Amgen's Decades-Long Leadership in Inflammation and Nephrology THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4,... Biopharmaceuticals, Mergers & Acquisitions Amgen, ChemoCentryx, TAVNEOS (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 4, 2022 Category: Pharmaceuticals Source Type: news

Medicapture Launches MVR Touchpro(TM): Includes New Medical-Grade, 10-Inch, Multi-Touch Mts101 Monitor with MVR(TM) Documentation and Recording System
New Patent Pending USB Powered MTS101 Monitor Meets Increasing Demand for Location Flexibility in the OR PLYMOUTH MEETING, Pa., Aug. 3, 2022 -- (Healthcare Sales & Marketing Network) -- MediCapture Inc., a leading manufacturer of medical imaging system... Devices, Product Launch MediCapture, MVR TouchPro (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 3, 2022 Category: Pharmaceuticals Source Type: news